AMGN vs CAG · P/E 24, rev $10.05B vs P/E 31, rev $11.28B
Amgen Inc (AMGN) versus ConAgra Foods Inc (CAG) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CAG revenue for 2026-05-31 was $11.28B. Net income was -$1.92B. Revenue was down 2.9% from 2025-05-25 to 2026-05-31. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
Not investment advice. Open the AMGN and CAG stock pages for the full models.
Not investment advice.